维普中文期刊产品整合服务
64篇 您的检索式:作者名="Rami H"
    题名 作者 年代 出处 被引量
1Bilateral same-session intravitreal injections of antivascular endothelial growth factors显示文摘AIM: To document the indications, safety and possible complications of bilateral same-session intravitreal antivascular endothelial growth factor(VEGF) injections performed in the ophthalmic operating room.METHODS: A retrospective case series study.Consecutive records of seventy four patients receiving simultaneous bilateral intravitreal injections of either ranibizumab or bevacizumab, between September 2010 and September 2013, were reviewed and the outcomes were assessed. Data collected included number of injections, indications for injections, pre-injection and post-injection visual acuity(VA), pre-injection and postinjection intraocular pressure and ocular and systemic complications/complaints after each injection.RESULTS: A total of 342 injections were administered to 74 patients, with a mean of 4.62 injections per patient.Seventy-three patients received bevacizumab(Avastin;Genentech Inc., South San Francisco, California, USA)alone, and only one patient received both bevacizumab and ranibizumab(Lucentis; Genentech Inc.) distributed between the injections. Pre- and post-injection VA follow-up measurements were available for 65 patients.Mean follow up period was 22 mo. The indications for initiating therapy were choroidal neovascular membrane from age-related macular degeneration(3 patients) and diabetic macular edema(71 patients). The mean Snellen VA before each injection was 6/22. The next post-injection follow-up mean Snellen VA was 6/20. One patient had a painful, culture-positive endophthalmitis in one eye 3d after bilateral bevacizumab. Another patient had a painless subconjunctival hemorrhage in one eye.No other ocular or systemic adverse side effects/complaints have been registered in this study group.CONCLUSION: Bilateral same-session intravitreal injections using a separate povidone-iodine preparation,speculum, needle, and syringe for each eye are well-tolerated. None of the subjects in this study requested to switch to alternating unilateral injections. Proper patient counseling as to the risk of complications with this procedure is necessary.Nakhleh E.Abu-Yaghi Ahmed N Shokry Rami H Abu-Sbeit 2014International Journal of Ophthalmology(English edition)2014,7,6:3
2Split-dose menthol-enhanced PEG vs PEG-ascorbic acid for colonoscopy preparation显示文摘AIM:To compare the efficacy and palatability of 4L polyethylene glycol electrolyte(PEG)plus sugar-free menthol candy(PEG+M)vs reduced-volume 2 L ascorbic acid-supplemented PEG(Asc PEG).METHODS:In a randomized controlled trial setting,ambulatory patients scheduled for elective colonoscopy were prospectively enrolled.Patients were randomized to receive either PEG+M or Asc PEG,both splitdosed with minimal dietary restriction.Palatability was assessed on a linear scale of 1 to 5(1=disgusting;5=tasty).Quality of preparation was scored by assignment-blinded endoscopists using the modified Aronchick and Ottawa scales.The main outcomes were the palatability and efficacy of the preparation.Secondary outcomes included patient willingness to retake the same preparation again in the future and completion of the prescribed preparation.RESULTS:Overall,200 patients were enrolled(100patients per arm).PEG+M was more palatable than Asc PEG(76%vs 62%,P=0.03).Completing the preparation was not different between study groups(91%PEG+M vs 86%Asc PEG,P=0.38)but more patients were willing to retake PEG+M(54%vs 40%respectively,P=0.047).There was no significant difference between PEG+M vs Asc PEG in adequate cleansing on both the modified Aronchick(82%vs77%,P=0.31)and the Ottawa scale(85%vs 74%,P=0.054).However,PEG+M was superior in the left colon on the Ottawa subsegmental score(score0-2:94%for PEG+M vs 81%for Asc PEG,P=0.005)and received significantly more excellent ratings than Asc PEG on the modified Aronchick scale(61%vs 43%,P=0.009).Both preparations performed less well in afternoon vs morning examinations(inadequate:29%vs 15.2%,P=0.02).CONCLUSION:4 L PEG plus menthol has better palatability and acceptability than 2 L ascorbic acidPEG and is associated with a higher rate of excellentpreparations;Clinicaltrial.gov identifier:NCT01788709.Ala I Sharara Ali H Harb Fayez S Sarkis Jean M Chalhoub Rami Badreddine Fadi H Mourad Mahmoud Othman Omar Masri 2015World Journal of Gastroenterology2015,21,6:2
3<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:2
4Selective hydroconversion of a model mixture and hydrotreated FCC gasoline for octane enhancement显示文摘GONZA'L EZA H RAMI'REZA J A 2004Catalysis Today2004,98,:1
5Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome显示文摘Sidhu J S Rajawat Y S Rami T G Gollob M H Wang Z Yuan R 2005Circulation2005,111,:1
6Aggregation of 3,5-dihydroxybenzyl alcohol based dendrimers and hyperbranched polymers, and encapsulation of DR1 in such dendritic aggregates显示文摘Olivier B Jared B Rami H 2004Inorg Chim Acta2004,357,13:1
7Pyridine and phenol removal using natural and synthetic apatites as low cost sorbents: Influence of porosity and surface interactions 显示文摘Bouyarmane H Asri S E Rami A 2010J Hazard Mater2010,181,123:1
8Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia显示文摘Rami A Bechmann I Stehle J H 2008Prog Neurobiol2008,85,3:1
9Potential use of phosphogypsum in concrete显示文摘Mohammad M Smadi Rami H Haddad Ahmad M Akour 1999Cem Concr Res1999,29,9:1
10Pyridine and phenol removal using natural and synthetic apatites as low cost sorbents:Influence ofporosity and surface interactions显示文摘Bouyarmane H Asri S E Rami A 2010Journal of Hazardous Materials2010,181,123:1
11MULTI-fs – A computer code for laser–plasma interaction in the femtosecond regime显示文摘R. Ramis K. Eidmann J. Meyer-ter-Vehn S. Hüller 2011Computer Physics Communications2011,,3:1
12Rice root genetic architecture: meta analysis from a drought QTL database显示文摘Courtois B Ahmadi N Khowaja F Price A H Rami J F Frouin J Hamelin C Ruiz M 2009Rice2009,,2:1
13<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:1
14Biorational insecticides: mechanism and cross resistance 显示文摘Isaac I Svetlana K Rami H 2005Archives lnsec Bio Phy2005,58,:1
15A multi-scale constitutive formulation for the nonlinear viscoelastic analysis of laminated composite materials and structures 显示文摘Haj-Ali Rami M Muliana Anastasia H 2004International Journal of Solids and Structures2004,41,:1
16Analysis for creep behavior and collapse of thick-section composite structures 显示文摘Muliana Anastasia H Haj-Ali Rami M 2006Composite Structures2006,73,:1
17Potential use of phosphor gypsum in concrete显示文摘Mohammad M Smadi Rami H Haddad Ahmad M Akour 1999Cement and Concrete Research1999,29,9:1
18Dietary zinc improves and calcium depresses growth and zinc uptake in rats fed rice bran 显示文摘Semi'ramis M A Domenea H R Torin J A 2001Nutrition Research2001,21,12:1
19Construction contracts: the cost of mistrust 显示文摘RAMY Z FRANCIS H 2003International Journal of Project Management2003,,21:1
20Cluster-based resource management in OFDMA femtocell networks with QoSguarantees显示文摘ABBAS H RAMI L and NADJIB A 2014IEEE Transactions on Vehicular Technology2014,63,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费